Latvia vs Oman: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Latvia
99.0%
in 2025
Oman
99.0%
in 2025
Latvia rank
1st
Oman rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Latvia
- Oman
How they compare
Latvia currently reports 99.0% against 99.0% in Oman, a difference of 0.0%.
Across all 26 years both countries report, Oman has been ahead every year.
Latvia ranks 1st and Oman ranks 1st of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.4% | 98.8% | 2.4% | Oman |
| 2010s | 94.6% | 98.8% | 4.2% | Oman |
| 2020s | 97.0% | 99.0% | 2.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Latvia or Oman?
- Latvia, at 99.0% against 99.0% in Oman as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Latvia and Oman?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Oman?
- 26 years are reported by both, from 2000 to 2025.
- How do Latvia and Oman rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Latvia ranks 1st and Oman ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.